Record share of U.S. businesses divert China investments. Top choice: Southeast Asia

BEIJING — Nearly half of U.S. businesses have redirected planned China investments to other regions over the past year — highest on record — the American Chamber of Commerce in Shanghai said Wednesday.

The business chamber’s survey of members came shortly after an escalation in U.S.-China trade tensions and a temporary rollback of some tariffs from mid-May. The two countries last month agreed to extend the trade truce by another 90 days, to mid-November.

“For a company, 90 days, that’s just way too short,” Eric Zheng, President of AmCham Shanghai, told reporters, pointing out that the supply chain planning is far longer term.

“At least we don’t need to deal with even higher tariffs [for now], but the issue is not going away, it’s still here,” Zheng said.

As many as 47% of the respondents in the survey, conducted from May 19 to June 20, said that they had diverted investments planned for China, primarily to Southeast Asia. That’s the highest share since the survey first featured the question about plans to shift investments away from China in 2017.

The Indian subcontinent, which includes Bangladesh, was the second-most popular destination for redirected investments, while the U.S. and Mexico ranked far lower.

U.S. President Donald Trump has sought to encourage businesses to bring manufacturing back to America, with Trump criticizing Apple‘s plans to expand production in India. A few companies, especially in advanced technology, have made high-profile announcements to invest in the U.S.

AmCham Shanghai’s members include Apple, Ford, Honeywell, Meta and Tesla. Jeffrey Lehman, the business group’s chair, pointed out that members are affected not just by U.S. tariffs on China, but Beijing’s retaliatory duties, since materials needed to build the product often come from the U.S.

U.S. tariffs on Chinese goods stand at nearly 58%, while China’s are around 33%, according to the U.S.-based Peterson Institute for International Economics. Tariff rates can vary by product.

Competition in China’s domestic market is also increasing, while confidence about the five-year local business outlook hit a record low for a fourth-straight year, the AmCham Shanghai study found.

Only 28% of respondents said that their China operating margins in 2024 were higher than that of their global business, while 33% said their China performance was actually worse.

U.S. companies also said their Chinese competitors were more advanced in six out of eight categories, especially speed to market and adoption of artificial intelligence. The survey found 41% of respondents said Chinese companies were more advanced in adopting AI, with the share rising to 62% in the retail and consumer industry.

AmCham Shanghai members only saw overwhelming advantages over their Chinese competition in product quality and development.

Beijing in recent years has ramped up its efforts to attract and retain foreign investment, with increased engagement and friendlier policy announcements. Earlier this year, China released an “action plan” that included measures for making it easier for foreign businesses to invest in biotechnology, while clarifying standards for government procurement.

However, the AmCham Shanghai survey still found that 14% of the respondents reported a worsening environment for foreign business in China, with the tech sector seeing the highest level of challenges at 31% of industry respondents.